GemVax&KAEL Co.,Ltd.

KOSDAQ:A082270 Rapporto sulle azioni

Cap. di mercato: ₩574.2b

GemVax&KAELLtd Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Sang-Jae Kim

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO3.0%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Some Confidence Is Lacking In GemVax&KAEL Co.,Ltd. (KOSDAQ:082270) As Shares Slide 28%

Nov 04
Some Confidence Is Lacking In GemVax&KAEL Co.,Ltd. (KOSDAQ:082270) As Shares Slide 28%

GemVax&KAEL Co.,Ltd.'s (KOSDAQ:082270) 30% Share Price Surge Not Quite Adding Up

Sep 19
GemVax&KAEL Co.,Ltd.'s (KOSDAQ:082270) 30% Share Price Surge Not Quite Adding Up

Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Jul 05
Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Apr 03
GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Feb 17
Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

Dec 26
Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

AMMINISTRATORE DELEGATO

Sang-Jae Kim (58 yo)

no data

Mandato

Mr. Sang-Jae Kim serves as Chief Executive Officer at GemVax&KAEL Co.,Ltd. He serves as Co-Chief Executive Officer of BIOVILL Co.,Ltd. (formerly known as KSCB Co.,Ltd.) Mr. Kim serves as the Chief Executiv...